versión imprimible

13th World ADC London 2023

Evvnt Promotion / evvnt
13.03.2023 - 16.03.2023  ExCeL London, 1 Western Gateway, E16 1XL London, United Kingdom
Time: 8:00 am to 4:00 pm
Temas de la conferencia
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and better than before!

With the recent approvals of ImmunoGen's ELAHERE, Astrazeneca and Daiichi Sankyo's DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.
La Sociedad Científica
Hanson Wade

Speakers: Aarti Jashnani, Principal Scientist, Bristol Myers Squibb, Abderrahman Laadem, Vice President, Global Head, Early Clinical Development, Daiichi Sankyo and more

Información e inscripción:
Ms. Jessica Durston
Salud Pública, Servicios de salud
Cuota del Congreso
GBP 2099.00 - GBP 5195.00
Los participantes esperaban
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Charité International AcademySwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthEuropean Health Forum GasteinÄrzte der Welt